| Literature DB >> 17686172 |
Thomas Rosemann1, Gunter Laux, Thomas Kuehlein.
Abstract
BACKGROUND: The aim of the study was to determine factors associated with functional disability in patients with OA.Entities:
Mesh:
Year: 2007 PMID: 17686172 PMCID: PMC1963449 DOI: 10.1186/1471-2474-8-79
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Characteristics of the study sample separated by gender (n = 1021)
| Gender | ||||
| Male (347/34.0%) | Female (674/66.0%) | |||
| mean | SD/% | mean | SD/% | |
| Age | 65.16 | 14.75 | 66.64 | 15.33 |
| Duration of OA (years) | 14.80 | 16.18 | 13.13 | 11.09 |
| Body Mass Index (BMI) | 28.39 | 4.26 | 28.12 | 5.16 |
| Educational Level (1–3)** | 2.61 | 1.11 | 2.38 | 0.83 |
| Married/Living in partnership** | 278 | 80.1 (%) | 376 | 55.8 (%) |
| Retired | 233 | 67.1 (%) | 482 | 71.5 (%) |
| Radiographic severity (Kellgren score)* | 2.76 | 0.92 | 2.53 | 0.77 |
| IPAQ score (MET/week) | 2356.2 | (1982.5) | 2108.3 | (1879.6) |
| No. of comorbid conditions (0–10) | 2.20 | 1.81 | 2.24 | 1.65 |
| PHQ-9 score | 15.33 | 4.76 | 15.95 | 4.63 |
| Comorbidities | n | % | n | % |
| High blood pressure** | 181 | 52.1 | 384 | 56.9 |
| Elevated cholesterol | 124 | 35.7 | 245 | 36.3 |
| Diabetes | 57 | 16.4 | 120 | 17.8 |
| Chronic Heart Failure | 63 | 18.1 | 131 | 19.4 |
| CVD | 62 | 17.8 | 70 | 10.3 |
| Ulcer/Gastritis | 77 | 22.1 | 146 | 21.6 |
| Asthma/COPD | 34 | 9.8 | 64 | 9.5 |
| Renal Insufficiency | 23 | 6.6 | 33 | 4.9 |
| Cancer | 21 | 6.1 | 16 | 2.4 |
| Stroke | 16 | 4.6 | 30 | 4.4 |
| Quality of life (AIMS2-SF dimensions): | ||||
| Lower body ** | 2.39 | 1.71 | 2.98 | 2.08 |
| Upper body | 1.38 | 2.33 | 1.54 | 2.22 |
| Symptom ** | 4.49 | 2.17 | 5.12 | 2.18 |
| Affect ** | 2.60 | 1.28 | 3.10 | 1.36 |
| Social | 4.75 | 1.95 | 4.61 | 1.76 |
| Work * (126 women/89 men) | 3.08 | 2.67 | 2.34 | 2.23 |
p < 0.05; ** p < 0.01 in group comparison (t-test, Fishers exact test respectively); Comparison of AIMS2-SF dimension by means of ANCOVA, adjusted for age, duration of disease, no. of comorbidities and PHQ-9 score
Localization of OA within the study sample
| total | Hip | Knee | |||
| Men | Women | Men | Women | ||
| Number of participants | 1021 | 191 | 236 | 156 | 438 |
| Unilateral OA (%) | 150 (14.7) | 32 (16.7) | 41 (17.3) | 32 (20.5) | 45 (10.2) |
| Bilateral OA (%) | 871 (85.3) | 159 (83.2) | 195 (82.6) | 124 (79.5) | 393 (89.7) |
Correlations of patients' demographic and clinical variables with the lower body scale of AIMS2-SF
| Lower body scale Spearman rho | ||
| Gender** | 0.121 | |
| Age* | 0.098 | |
| Education** | -0.137 | |
| Marital status* | -0.081 | |
| Disease duration** | 0.177 | |
| BMI** | 0.159 | |
| IPAQ score (MET/week)** | 0.136 | |
| Kellgren score* | 0.298 | |
| No. of comorbidities** | 0.138 | |
| PHQ-9 sum score** | 0.445 | |
| AIMS 2-SF scales | Upper body* | 0.210 |
| Symptom** | 0.515 | |
| Affect** | 0.470 | |
| Social** | 0.199 | |
Level of significance: *p < 0.05 **p < 0.01;
Predictors of functional impairment of the lower body assessed by stepwise multiple regression model
| Dependent: Symptom | B | SE | T | P |
| PHQ-9 score | 0.446 | 0.117 | 3.960 | <0.0009 |
| Symptom* | 0.412 | 0.114 | 3.064 | 0.001 |
| Educational level | -0.279 | 0.149 | -2.092 | 0.029 |
| BMI | 0.332 | 0.072 | 2.022 | 0.005 |
| Social* | 0.201 | 0.098 | 2.034 | 0.042 |
| Age | 0.178 | 0.102 | 1.998 | 0.001 |
* AIMS2-SF scale